“…The six remaining studies described costs without (surgical) cohort [51,54,57] or compared auto-and allograft techniques for ACDF, but costs are represented separately [Table 1] [52, 53,55]. There was a large variety in the evaluated study populations, as some studies only included patients with radiculopathy [46,47,49,51,53] or myelopathy [48,66], and other studies specifically evaluated singlelevel surgeries [46,49,54,55,59,63,69,70] in contrast to those that only assessed multi-level surgeries [43,48,56,61,64].…”